Exploring the Drug Discovery and Development Landscape with Boehringer Ingelheim

This event has concluded. Thank you for attending this event. Check out our Events page for more such events!


Come join us on 5 Dec 2023 as we plug in to learn more about Boehringer Ingelheim (BI)’s initiatives to support academic research, as well as their partnering, licensing and venture investment interests! Our guest speaker, BI representative Dr Namiko Yamashita, will be presenting on the following topics:

  • opnMe | Establishing connections with external scientists through various tracks
  • BI Venture Fund | Investment opportunities with interests in early stages from company creation up to Series A
  • Research Beyond Borders (RBB) | In-licensing and collaboration outside of BI’s core disease areas
  • Business Development & Licensing (BD&L) | Seeking opportunities for in-licensing within BI’s core disease areas.

Don’t miss this great opportunity to gain industry insights from a leading research-driven biopharmaceutical company and discover new avenues for collaboration. Register now!

📅: 5 December 2023, Tuesday

🕚: 11am – 12pm

📍: Online Zoom webinar

This is a fully virtual event – your zoom link will be sent to the indicated email address shortly after registration.

Due to the sensitivity of information to be presented and the speaker’s preference, we strongly advise against capturing the contents of the slides through any form of media.


Kindly note that screen captures may be taken during this event. By taking part in this event, you are consenting that images taken during the event can be used by EDDC for any form of publicity including but not limited to our website, social media and publication purposes.


By registering for this webinar, you hereby agree that EDDC may collect, obtain, store and process your personal data for a relevant calendar invite for the above-mentioned webinar.

Your information will not be disclosed externally or be kept beyond this seminar.

Related Articles